A new sol-gel procedure using micellar solutions has been developed to
immobilize local anesthetic drugs in optically transparent glass. Dibucaine
was selected as a direct emission probe at 77 K for determining the forms of
the anesthetic drug (free base, monoprotonated, and/or diprotonated) and its
location (hydrophobic core, interfacial layer or hydrophilic region) in
micelles. The photophysical properties of local anesthetics obtained in gels
are compared to those in solutions. During the gelation stage, the
predominant drug species was identified as free base dibucaine embedded in
the hydrophobic core of neutral as well as charged micelles. This
observation suggests that the micellar interface was modified by the large
hydrophilic gel surface during the gelation stage. The modified micellar
interface allows an increase in the partition of free base dibucaine into
the hydrophobic region. At the xerogel stage, however, the collapse of
micellar structure provides a direct interaction of dibucaine with the
acidic gel surface, leading to a formation of diprotonated dibucaine. The
results are discussed in terms of molecular basis of pharmacological
implications such as drug delivery, release, and transport under
microencapsulation conditions.